Race against brain swelling: High-Dose blood treatment tested for sudden liver failure
NCT ID NCT06515145
Summary
This study aims to see if exchanging a larger volume of a patient's blood plasma works better than the standard amount to reduce dangerous brain swelling in people with sudden liver failure. Sixty eligible patients will be randomly assigned to receive either the high-volume or standard-volume treatment. The main goal is to see which approach helps the brain swelling improve faster and leads to better survival without needing a liver transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
Conditions
Explore the condition pages connected to this study.